Elizabeth Goodman has been appointed Senior Managing Director at FTI Consulting's Healthcare and Life Sciences practice.
Quiver AI Summary
FTI Consulting, Inc. has appointed Dr. Elizabeth (Liz) Goodman as a Senior Managing Director in its Healthcare and Life Sciences practice, focusing on Strategic Communications. With over 30 years of experience in healthcare, including expertise in Medicare and Medicaid, Dr. Goodman will help clients navigate the complex healthcare environment, advising senior executives on balancing brand equity, stakeholder relationships, and regulatory pressures. Previously, she held key positions at Commonwealth Care Alliance and America's Health Insurance Plans. Her addition continues FTI's expansion in the sector, enhancing its capability to support healthcare organizations in addressing critical business challenges.
Potential Positives
- FTI Consulting has strengthened its Healthcare and Life Sciences practice by appointing Dr. Elizabeth Goodman, who brings over 30 years of healthcare experience, enhancing the firm's capability to advise clients in a complex regulatory environment.
- Dr. Goodman's expertise in healthcare policy and law positions FTI Consulting to better assist clients in navigating regulatory challenges and enhancing their strategic communications, potentially leading to improved client relationships and business outcomes.
- The appointment reflects FTI Consulting's commitment to expanding its team with seasoned professionals, indicating a proactive approach to meeting the evolving needs of the healthcare sector.
- The company reported $3.70 billion in revenues for the fiscal year 2024, showcasing its strong financial performance and positioning it well for further growth and investment in human capital like Dr. Goodman.
Potential Negatives
- The appointment of Dr. Goodman might draw scrutiny regarding FTI Consulting's need for leadership overhaul amidst ongoing challenges in the healthcare sector, indicating potential instability or a lack of confidence in current strategies.
- Dr. Goodman's prior roles in other organizations may lead to higher expectations from clients, putting pressure on FTI Consulting to deliver results quickly in a complex and competitive market.
- While expanding the Healthcare and Life Sciences practice, there may be concerns about resource allocation and whether the company can effectively manage the growing complexity of client needs, which could affect overall performance and reputation.
FAQ
Who is Elizabeth Goodman?
Elizabeth (Liz) Goodman is the newly appointed Senior Managing Director in the Healthcare and Life Sciences practice at FTI Consulting.
What experience does Dr. Goodman bring to FTI Consulting?
Dr. Goodman has over 30 years of experience in healthcare, health insurance, and health law and policy at both state and federal levels.
What will Dr. Goodman do at FTI Consulting?
Dr. Goodman will advise healthcare payers and providers on navigating complex regulatory and operational challenges in the healthcare business environment.
What is the focus of FTI Consulting's Healthcare and Life Sciences practice?
The practice focuses on helping clients manage brand equity, stakeholder relationships, and mitigate financial and reputational risks.
Where can more information about FTI Consulting be found?
More information about FTI Consulting can be found on their official website at https://www.fticonsulting.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$FCN Insider Trading Activity
$FCN insiders have traded $FCN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $FCN stock by insiders over the last 6 months:
- AJAY SABHERWAL (Chief Financial Officer) sold 5,236 shares for an estimated $861,845
- CURTIS P LU (General Counsel) sold 4,953 shares for an estimated $785,545
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$FCN Hedge Fund Activity
We have seen 197 institutional investors add shares of $FCN stock to their portfolio, and 210 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEUBERGER BERMAN GROUP LLC removed 645,368 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $105,891,981
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 565,672 shares (-55.5%) from their portfolio in Q1 2025, for an estimated $92,815,461
- PACER ADVISORS, INC. removed 518,687 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $85,106,162
- STEPHENS INVESTMENT MANAGEMENT GROUP LLC removed 474,292 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $77,821,831
- GREENVALE CAPITAL LLP added 360,220 shares (+inf%) to their portfolio in Q1 2025, for an estimated $59,104,897
- JACOBS LEVY EQUITY MANAGEMENT, INC added 292,615 shares (+1668.1%) to their portfolio in Q1 2025, for an estimated $48,012,269
- GOLDMAN SACHS GROUP INC removed 288,986 shares (-85.4%) from their portfolio in Q1 2025, for an estimated $47,416,822
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$FCN Price Targets
Multiple analysts have issued price targets for $FCN recently. We have seen 2 analysts offer price targets for $FCN in the last 6 months, with a median target of $175.5.
Here are some recent targets:
- Tobey Sommer from Truist Securities set a target price of $178.0 on 04/02/2025
- James Yaro from Goldman Sachs set a target price of $173.0 on 02/21/2025
Full Release
WASHINGTON, July 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Elizabeth (Liz) Goodman as a Senior Managing Director in the Healthcare and Life Sciences practice within the firm’s Strategic Communications segment.
Dr. Goodman, who is based in Washington, D.C., joins FTI Consulting with more than 30 years of experience in healthcare, health insurance and health law and policy at the state and federal levels, including a focus on Medicare, Medicaid and long-term services and supports. Dr. Goodman has a deep understanding of regulatory and operational challenges facing healthcare payers and providers.
In her role at FTI Consulting, Dr. Goodman will help healthcare and life sciences payers and providers navigate the increasingly complex and polarized healthcare business environment. She will advise C-suite, boards and senior executives in the challenging work of balancing competing goals of enhancing brand equity, managing stakeholder expectations and relationships, and mitigating financial and reputational risks, while minimizing political and regulatory pressures and elevating executive profiles.
“Liz is an accomplished leader and brings with her a deep understanding of the healthcare industry and its evolving business and regulatory environment,” said Lauren Crawford Shaver , Americas Head of Healthcare and Life Sciences for the Strategic Communications segment at FTI Consulting. “She will play a key role in working with FTI Consulting’s global multidisciplinary healthcare and life sciences team to help clients build differentiated growth strategies enhanced by integrated solutions in communications, crisis management, risk and investigations and business transformation.”
Prior to joining FTI Consulting, Dr. Goodman served as Chief Legal and Public Affairs Officer at Commonwealth Care Alliance (“CCA”) where she was responsible for CCA’s legal, corporate governance, public relations, public policy and federal and state government affairs functions. Prior to CCA, she served as Executive Vice President of Government Affairs and Innovation at America’s Health Insurance Plans (“AHIP”), the national trade association representing the health insurance industry.
Commenting on her appointment, Dr. Goodman said, “Everyone in healthcare is grappling with mounting pressures, including regulatory shifts, evolving care models and changing patient, payer and provider expectations. I look forward to working with the impressive roster of experts at FTI Consulting as we work with payers, providers and other healthcare and life sciences organizations to identify strategies and solutions to address a growing list of business-critical challenges.”
Dr. Goodman’s hiring continues the expansion of the Healthcare and Life Sciences practice within the Strategic Communications segment at FTI Consulting and follows the recent appointments of public affairs and corporate reputation professionals Shelley DuBois, Brian Doheny, Audrey Jackson, Shana Marino, Emma Winstead, Ian Flowers and Grace McDonnell.
About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 7,900 employees located in 32 countries and territories as of June 30, 2025. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.70 billion in revenues during fiscal year 2024. More information can be found at
https://www.fticonsulting.com
.
FTI Consulting, Inc.
555 12
th
Street NW
Washington, DC 20004
+1.202.312.9100
Investor Contact:
Mollie Hawkes
+1.617.747.1791
[email protected]
Media Contact:
Nick Emmons
+1.617.510.1676
[email protected]
